Ignite Creation Date:
2025-12-24 @ 4:32 PM
Ignite Modification Date:
2026-05-29 @ 8:18 AM
Study NCT ID:
NCT01271166
Status:
TERMINATED
Last Update Posted:
2011-01-06
First Post:
2011-01-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CSTI571BAU14
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
External Affairs
Old Organization:
Novartis Pharmaceuticals